Bleakley Financial Group LLC lifted its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Free Report) by 30.1% in the fourth quarter, HoldingsChannel.com reports. The firm owned 41,691 ...
Maravai Lifesciences Holdings Inc (MRVI) stock has reached a new 52-week low, touching down at $4.19, representing a steep 64% decline from its 52-week high of $11.55. The $1.09 billion market cap ...
In a report released today, Brandon Couillard from Wells Fargo maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research ...
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Stock traders acquired 1,002 put options on the company.
RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on February 4 and set a ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results